Concorde Asset Management, LLC

Position in LLY — ELI LILLY & Co

CIK 1631773 ANN ARBOR, MI

Position in LLY

as of Jun 30, 2026 · filed Aug 18, 2026 Compact

Position Value

$782,028

+$197,975 QoQ

Shares Held

652

+2.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.98%

of 13F equity value

Holder Rank

#3,354

of 4,605 holders

Holding Since

Jun 2021

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Concorde Asset Management, LLC holds $2,975,283 across 6 Drug Manufacturers - General names. LLY ranks #1 (26.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	652	$782,028
2	JNJ	Johnson & Johnson	2,819	$715,941
3	ABBV	AbbVie Inc.	2,581	$649,482
4	AMGN	Amgen Inc	856	$309,974
5	PFE	Pfizer Inc	12,833	$309,018
6	GILD	Gilead Sciences, Inc.	1,653	$208,840

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$782,028	652	+2.7%	Shares	Sole	2026-08-18
2026-03-31	$584,053	635	-28.7%	Shares	Sole	2026-06-01
2025-12-31	$956,465	890	+1.0%	Shares	Sole	2026-02-13
2025-09-30	$672,203	881	-13.2%	Shares	Sole	2025-11-14
2025-03-31	$838,298	1,015	+12.8%	Shares	Sole	2025-05-15
2024-12-31	$694,800	900	-18.6%	Shares	Sole	2025-02-13
2024-09-30	$979,849	1,106	-0.4%	Shares	Sole	2024-11-12
2024-06-30	$1,004,971	1,110	+13.6%	Shares	Sole	2024-08-12
2024-03-31	$760,066	977	+2.2%	Shares	Sole	2024-05-15
2023-12-31	$557,271	956	-8.8%	Shares	Sole	2024-02-15
2023-09-30	$562,909	1,048	+3.5%	Shares	Sole	2023-11-13
2023-06-30	$475,075	1,013	+0.4%	Shares	Sole	2023-07-25
2022-12-31	$369,132	1,009	-0.1%	Shares	Sole	2023-02-02
2022-09-30	$326,582	1,010	+3.5%	Shares	Sole	2022-10-31
2022-03-31	$279,496	976	+5.1%	Shares	Sole	2022-04-22
2021-09-30	$214,644	929	+5.1%	Shares	Sole	2021-10-21
2021-06-30	$202,895	884	—	Shares	Sole	2021-07-20
No filing history on record for this holder in this stock.